Emily is an articling student in our Toronto office. She attended both the University of Toronto and the University of Ottawa to earn her Juris Doctor.
Before pursuing law, Emily completed a Ph.D. in physiology at the University of Toronto where her research focus was to generate insulin producing cells for patients living with Type 1 Diabetes. Following her Ph.D, she worked as a postdoctoral fellow and then as a scientist where she genetically modified pluripotent stem cells for cancer therapy.
Emily published five papers and one patent. She was awarded Oral Presentation winner at the University of Toronto’s annual Frontiers in Physiology Conference for her presentation about her thesis topic: Using stem cells for the treatment of Type 1 Diabetes. Emily also won the University of Toronto’s 3 Minute Thesis Competition, People’s Choice Award.
While pursuing her law degree at the University of Ottawa, Emily served as an assistant editor to the Ottawa Law Review. She was selected as a Technoship Fellow by the Centre for Law, Technology and Society (CLTS), where she carried out research under the supervision of a faculty member. She also worked as a research assistant at the university, further developing her legal research skills.
Emily looks forward to returning to Smart & Biggar after previously working with the firm as a summer student. She is eager to collaborate with leaders in the field and further develop her legal skills.
Qualifications
- News
- Speaking
- In the Media
- “Journeys in Commercialization”, guest speaker at a panel, Medicine by Design’s annual commercialization course, University of Toronto, 2024
- 4th year undergraduate course: PSL404 Regenerative Medicine, guest lecturer, University of Toronto, 2021
- Canada First Research Excellence Fund meeting, guest speaker, 2020
Publications
- GP2-enriched pancreatic progenitors give rise to functional beta cells in vivo and eliminate the risk of teratoma formation. Stem Cell Reports. 2022.
- Sufu- and Spop-mediated downregulation of Hedgehog signaling promotes beta cell differentiation through organ-specific niche signals. Nature Communications. 10, 4647, 2019.
- Stem Cells, Self-Renewal, and Lineage Commitment in the Endocrine System. Frontiers in Endocrinology. 10 (2019).
- Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors. J. Vis. Exp. (121), e55265, doi:10.3791/55265, 2017.
- GP2 is a specific cell surface marker of human pancreatic progenitors. Nature Communications. 331, 2017.